Abeona Therapeutics Inc (NAS:ABEO)
$ 6.21 0.17 (2.81%) Market Cap: 268.98 Mil Enterprise Value: 162.08 Mil PE Ratio: 0 PB Ratio: 3.53 GF Score: 52/100

Q3 2021 Abeona Therapeutics Inc Earnings Call Transcript

Nov 17, 2021 / 01:30PM GMT
Release Date Price: $21.25 (-2.42%)
Operator

Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Abeona Q3 2021 Earnings Call. (Operator Instructions) I would now like to turn the call over to Greg Gin, Head of Investor Relations. Please go ahead.

Gregory Gin
Abeona Therapeutics Inc. - VP of IR & Corporate Communications

Thank you, Kelly. Good morning, everyone. I would like to welcome and thank you for joining us on our third quarter 2021 conference call. The press release announcing the third quarter results and recent operational progress is available on our website at www.abeonatherapeutics.com.

On the call today with prepared remarks are Vish Seshadri, CEO of Abeona; and Ed Carr, CFO. After the prepared remarks, we'll host a Q&A session. We are also joined by Dr. Brian Kevany, our Chief Technical Officer.

Before we start, I will review our safe harbor statement. Remarks made during today's call may contain projections and forward-looking statements regarding future events.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot